ID

15843

Description

Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00590902

Link

https://clinicaltrials.gov/show/NCT00590902

Keywords

  1. 6/15/16 6/15/16 -
Uploaded on

June 15, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Bronchioloalveolar Cell Variant of Non-small Cell Lung Cancer NCT00590902

Eligibility Bronchioloalveolar Cell Variant of Non-small Cell Lung Cancer NCT00590902

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
either bronchioloalveolar cell carcinoma or a variant thereof after review
Description

bronchioloalveolar cell carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0007120
clinical stage iiib (malignant pleural or pericardial effusion) or iv or recurrent/medically inoperable disease
Description

clinical stage iiib

Data type

boolean

Alias
UMLS CUI [1]
C0205580
UMLS CUI [2]
C0205585
measurable or evaluable indicator lesions
Description

evaluable indicator lesions

Data type

boolean

Alias
UMLS CUI [1]
C1513041
no prior or one chemotherapy regimen for nsclc
Description

chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0007131
three weeks since last chemotherapy, and three weeks since prior radiation therapy to a major bone-marrow containing area
Description

therapeutic procedures

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0205146
UMLS CUI [1,3]
C1522449
UMLS CUI [2]
C0392920
karnofsky performance status > or = to 80% or ecog performance status ≤ or = to 1
Description

karnofsky performance status

Data type

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1520224
life expectancy > or = to 8 weeks
Description

life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
adequate hematologic, renal and/or hepatic function: wbc > or = to 3,000/ul, hemoglobin > or = to 9.0 g/dl, platelet count > or = to 100,000/ul, total bilirubin < or = to 1.0 mg/dl, ast < than or = to 2.5 x unl, creatinine < or = to 1.5 mg/dl or clcr > or = to 55ml/min.
Description

lab tests

Data type

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0005821
UMLS CUI [4]
C0201913
UMLS CUI [5]
C0201899
UMLS CUI [6]
C0201976
UMLS CUI [7]
C0373595
effective contraception
Description

effective contraception

Data type

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior exposure to osi-774 or other treatments targeting the her family axis (e.g.-trastuzumab, zd1839, c225, etc.)
Description

exposure to osi-774

Data type

boolean

Alias
UMLS CUI [1,1]
C1135137
UMLS CUI [1,2]
C0332157
two or more prior chemotherapy regimens
Description

chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0449788
concurrent active cancer
Description

active cancer

Data type

boolean

Alias
UMLS CUI [1]
C0006826
uncontrolled central nervous system metastases (i.e. any known cns lesion which is radiographically unstable, symptomatic and/or requiring escalating doses of corticosteroids)
Description

central nervous system metastases

Data type

boolean

Alias
UMLS CUI [1]
C0686377
pregnant or lactating women
Description

pregnancy or lactating

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
malignancies within the past 5 years except for adequately treated carcinoma of the cervix or basal or squamous cell carcinomas of the skin
Description

malignancies

Data type

boolean

Alias
UMLS CUI [1]
C0006826
prior systemic cytotoxic chemotherapy for other malignant disease
Description

systemic cytotoxic chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0677881
significant medical history or unstable medical condition (unstable systemic disease: congestive heart failure, recent mi, unstable angina, active infection, uncontrolled hypertension).
Description

comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0009488

Similar models

Eligibility Bronchioloalveolar Cell Variant of Non-small Cell Lung Cancer NCT00590902

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
bronchioloalveolar cell carcinoma
Item
either bronchioloalveolar cell carcinoma or a variant thereof after review
boolean
C0007120 (UMLS CUI [1])
clinical stage iiib
Item
clinical stage iiib (malignant pleural or pericardial effusion) or iv or recurrent/medically inoperable disease
boolean
C0205580 (UMLS CUI [1])
C0205585 (UMLS CUI [2])
evaluable indicator lesions
Item
measurable or evaluable indicator lesions
boolean
C1513041 (UMLS CUI [1])
chemotherapy
Item
no prior or one chemotherapy regimen for nsclc
boolean
C0392920 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
therapeutic procedures
Item
three weeks since last chemotherapy, and three weeks since prior radiation therapy to a major bone-marrow containing area
boolean
C0005953 (UMLS CUI [1,1])
C0205146 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2])
karnofsky performance status
Item
karnofsky performance status > or = to 80% or ecog performance status ≤ or = to 1
boolean
C0206065 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
life expectancy
Item
life expectancy > or = to 8 weeks
boolean
C0023671 (UMLS CUI [1])
lab tests
Item
adequate hematologic, renal and/or hepatic function: wbc > or = to 3,000/ul, hemoglobin > or = to 9.0 g/dl, platelet count > or = to 100,000/ul, total bilirubin < or = to 1.0 mg/dl, ast < than or = to 2.5 x unl, creatinine < or = to 1.5 mg/dl or clcr > or = to 55ml/min.
boolean
C0023508 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0005821 (UMLS CUI [3])
C0201913 (UMLS CUI [4])
C0201899 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
C0373595 (UMLS CUI [7])
effective contraception
Item
effective contraception
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
exposure to osi-774
Item
prior exposure to osi-774 or other treatments targeting the her family axis (e.g.-trastuzumab, zd1839, c225, etc.)
boolean
C1135137 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
chemotherapy
Item
two or more prior chemotherapy regimens
boolean
C0392920 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
active cancer
Item
concurrent active cancer
boolean
C0006826 (UMLS CUI [1])
central nervous system metastases
Item
uncontrolled central nervous system metastases (i.e. any known cns lesion which is radiographically unstable, symptomatic and/or requiring escalating doses of corticosteroids)
boolean
C0686377 (UMLS CUI [1])
pregnancy or lactating
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
malignancies
Item
malignancies within the past 5 years except for adequately treated carcinoma of the cervix or basal or squamous cell carcinomas of the skin
boolean
C0006826 (UMLS CUI [1])
systemic cytotoxic chemotherapy
Item
prior systemic cytotoxic chemotherapy for other malignant disease
boolean
C0677881 (UMLS CUI [1])
comorbidity
Item
significant medical history or unstable medical condition (unstable systemic disease: congestive heart failure, recent mi, unstable angina, active infection, uncontrolled hypertension).
boolean
C0009488 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial